Clinical Trials
24 trialsCHIPPI
Centre Oscar Lambret
KOV-HIPEC-02R
National Cancer Center, Korea
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Loma Linda University
TOASTIT
Mayo Clinic
CRS/HIPEC
Mercy Medical Center
Intraperitoneal LSTA1 in CRS-HIPEC
University of California, San Diego
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
Fudan University
OvIP1
University Hospital, Ghent
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
Cantonal Hospital of St. Gallen
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Instituto Nacional de Cancerologia de Mexico
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
University of Kansas Medical Center
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Ruhr University of Bochum
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
Professor Fernando Figueira Integral Medicine Institute
HIPECOV
Zhongnan Hospital
HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC)
Second Affiliated Hospital, School of Medicine, Zhejiang University
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Masonic Cancer Center, University of Minnesota
Comparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian Cancer
Ajou University School of Medicine
HIPEC/IPHC
Bay Area Gynecology Oncology
hipecova
Hospital General de Ciudad Real
Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
Jules Bordet Institute
CHORINE
A.O. Ospedale Papa Giovanni XXIII
IPHC
Catholic University of the Sacred Heart